{"database": "lobbying", "table": "lobbying_activities", "rows": [[2770137, "555befa9-0d9c-4a79-a598-3cdfc38ecc75", "Q1", "AMERICAN SOCIETY OF NEPHROLOGY", 80656, "AMERICAN SOCIETY OF NEPHROLOGY", 2022, "first_quarter", "HCR", "FY22 Congressional appropriations: -Increase NIH funds, supporting $6.5 billion for NIH in general including $2.2 billion for kidney research at NIDDK -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $5 million FY23 Congressional appropriations: -Increase NIH funds, including $632 million increase for NIDDK to support kidney research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $15 million Other: -Enact the Living Donor Protection Act (HR1255 S377) -Enact the Jack Reyonlds Medigap Expansion Act (HR1676) -Enact the Improving Access to Home Dialysis Act of (HR5426)", "Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", 0, 0, "2022-04-06T12:36:05-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2770137"], "units": {}, "query_ms": 0.22329902276396751, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}